Skip to main content
. 2017 Jul 9;14(3):2101–2107. doi: 10.3892/etm.2017.4740

Table I.

IC50 values for gemcitabine in PDAC cell lines with or without GC7 (16 µM) treatment.

IC50 (µg/ml)

PDAC cell line Gemcitabine Gemcitabine+GC7
Panc-1 45.95±1.54 23.46±0.59a
BxPC-3 5.47±0.18 2.74±0.14a
T3-M4 11.66±0.33 6.60±0.40a
a

P<0.05 vs. gemcitabine alone. PDAC, pancreatic ductal adenocarcinoma; IC50, half maximal inhibitory concentration.